Evidence map›Paper›PMID 34920750›Full record

ArticleCritical care (London, England)2021

Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different?

Lies Langouche, Greet Van den Berghe, Jan Gunst

Open access · goldAbstract readLetter
In one paragraph

Article in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Diabetes and COVID-19: Short- and Long-Term Consequences.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2022
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lies LangoucheClinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.ORCID 0000-0002-8564-6809
Greet Van den BergheClinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.ORCID 0000-0002-5320-1362
Jan GunstClinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. jan.gunst@kuleuven.be.ORCID 0000-0003-2470-6393
KU Leuven · BE

Funding

Fonds Wetenschappelijk Onderzoek G069421NFonds Wetenschappelijk Onderzoek T003617NH2020 European Research Council AdvG 2017-785809KU Leuven C24/17/070Universitaire Ziekenhuizen Leuven, KU Leuven Postdoctoral research fellowshipVlaamse regering METH14/06
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HyperglycemiaInsulin ResistanceCritical IllnessHumansSARS-CoV-2COVID-19DiabetesHyperglycemiaInsulin

Identifiers

PMID34920750
PMCPMC8680062
OpenAlexW4200112302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.